Clinical Trial Update: Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing YW17 (Laronidase-CinnaGen) with Aldurazyme in patients with mucopolysaccharidosis type I has completed, evaluating efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type

Drugs mentioned

• Aldurazyme (Laronidase)
• YW17 (Laronidase)

Snippet

Sponsor: Cinnagen | Conditions: Mucopolysaccharidosis Type 1 | Phase 3 | Status: COMPLETED